Excel's Power Query lets you build report-level and table-level timestamps that update on refresh.

Nearly every major product family needs immediate patching, from Windows to Office to Microsoft Edge, SQL Server, and even ...

Mercor, a popular AI recruiting startup, has confirmed a security incident linked to a supply chain attack involving the open source project LiteLLM. The AI startup told TechCrunch on Tuesday that it ...

MIDLAND COUNTY, Texas — Two men are behind bars after being arrested Tuesday in connection with a late February assault that later turned into a murder, according to law enforcement officials. A third ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Microsoft confirms critical Excel security vulnerability. Security experts have warned that ...

Comparable long-term effectiveness to classic corticosteroids, both prednisone (p=0.8587) and deflazacort (p=0.6544), based on time to loss of ambulation 80% fewer patients with vertebral fractures (8 ...

SQL Server backups cannot be restored to older versions directly. Use Export and Import Data-Tier Application for cross-version database migration. Reconfigure permissions, logins, and connection ...

BRUSSELS, Feb 3 (Reuters) - Long delays to get power grid connections are challenging Amazon's (AMZN.O), opens new tab plans to expand data centers in Europe, the company told Reuters, as industries ...

West Virginia Public Service Commission Chairwoman Charlotte Lane briefs lawmakers Monday on progress on the pro-coal provisions in a new law aimed at attracting data centers and microgrids. (Photo ...

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Deucravacitinib was associated with improvements in clinical responses and patient reported outcomes, as well as inhibition of radiographic progression, when compared with placebo. Deucravacitinib was ...